Ignite Creation Date:
2024-05-06 @ 8:25 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06374251
Status:
RECRUITING
Last Update Posted:
2024-04-18
First Post:
2024-04-15
Brief Title:
Narrative Medicine for Improving Well-Being in Patients With Gastrointestinal Cancers
Sponsor:
University of Southern California
Organization:
University of Southern California
Study Overview
Official Title:
Can Narrative Medicine Methods Improve Well-Being in Patients With GI Malignancies
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This clinical trial assesses whether narrative medicine methods may improve the sense of well-being among gastrointestinal GI digestive system cancer patients Narrative medicine is a clinical approach where providers can use a patients own narrative perspective of their illness to promote healing and resilience By applying narrative medicines main tool close reading to clinical practice clinicians learn to listen and attend to patients more deeply This allows for freer communication and the creation of a healthcare encounter that centers on the psychological and emotional well being of the patient in addition to their medical conditions Narrative medicine can include close reading creative or reflective writing and discussion These methods may help patients with GI cancer to reflect on their life stories both inside and outside of their illness experience and help them gather skills to optimize their well-being
Detailed Description:
PRIMARY OBJECTIVES
I To assess the feasibility of implementing narrative medicine tools in serial workshops with patients with malignancy
II To determine if narrative medicine interventions improve markers and expressions of well-being
DESCRIPTIVE OBJECTIVES
I To estimate changes in markers and expressions of well-being after 3 sessions of narrative medicine intervention
II To determine through qualitative methods if patients find benefit from the intervention regarding their well-being
III To decide whether to expand these kinds of interventions to a larger study with control group
OUTLINE
Patients participate in narrative medicine sessions over 60 minutes once every 2 weeks Q2W for 3 sessions
After completion of study intervention patients are followed up at 1 and 3 months
I To assess the feasibility of implementing narrative medicine tools in serial workshops with patients with malignancy
II To determine if narrative medicine interventions improve markers and expressions of well-being
DESCRIPTIVE OBJECTIVES
I To estimate changes in markers and expressions of well-being after 3 sessions of narrative medicine intervention
II To determine through qualitative methods if patients find benefit from the intervention regarding their well-being
III To decide whether to expand these kinds of interventions to a larger study with control group
OUTLINE
Patients participate in narrative medicine sessions over 60 minutes once every 2 weeks Q2W for 3 sessions
After completion of study intervention patients are followed up at 1 and 3 months
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| P30CA014089 | NIH | USC Norris Comprehensive Cancer Center | httpsreporternihgovquickSearchP30CA014089 |
| NCI-2023-08890 | REGISTRY | None | None |
| 0S-23-2 | OTHER | None | None |